175 related articles for article (PubMed ID: 30036625)
1. TNK2 as a key drug target for the treatment of metastatic colorectal cancer.
Qi L; Ding Y
Int J Biol Macromol; 2018 Nov; 119():48-52. PubMed ID: 30036625
[TBL] [Abstract][Full Text] [Related]
2. The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer.
Wu X; Zahari MS; Renuse S; Kelkar DS; Barbhuiya MA; Rojas PL; Stearns V; Gabrielson E; Malla P; Sukumar S; Mahajan NP; Pandey A
Oncotarget; 2017 Jan; 8(2):2971-2983. PubMed ID: 27902967
[TBL] [Abstract][Full Text] [Related]
3. Development of novel ACK1/TNK2 inhibitors using a fragment-based approach.
Lawrence HR; Mahajan K; Luo Y; Zhang D; Tindall N; Huseyin M; Gevariya H; Kazi S; Ozcan S; Mahajan NP; Lawrence NJ
J Med Chem; 2015 Mar; 58(6):2746-63. PubMed ID: 25699576
[TBL] [Abstract][Full Text] [Related]
4. In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1.
Khedkar HN; Wang YC; Yadav VK; Srivastava P; Lawal B; Mokgautsi N; Sumitra MR; Wu ATH; Huang HS
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072728
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects.
Huang TH; Mokgautsi N; Huang YJ; Wu ATH; Huang HS
Cells; 2021 Aug; 10(8):. PubMed ID: 34440739
[TBL] [Abstract][Full Text] [Related]
6. Integration of genetic variants and gene network for drug repurposing in colorectal cancer.
Irham LM; Wong HS; Chou WH; Adikusuma W; Mugiyanto E; Huang WC; Chang WC
Pharmacol Res; 2020 Nov; 161():105203. PubMed ID: 32950641
[TBL] [Abstract][Full Text] [Related]
7. Screening for implicated genes in colorectal cancer using whole‑genome gene expression profiling.
Sun LC; Qian HX
Mol Med Rep; 2018 Jun; 17(6):8260-8268. PubMed ID: 29658574
[TBL] [Abstract][Full Text] [Related]
8. Tropomyosin-related kinase B/brain derived-neurotrophic factor signaling pathway as a potential therapeutic target for colorectal cancer.
Akil H; Perraud A; Jauberteau MO; Mathonnet M
World J Gastroenterol; 2016 Jan; 22(2):490-500. PubMed ID: 26811602
[TBL] [Abstract][Full Text] [Related]
9. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
10. Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis.
Maxson JE; Abel ML; Wang J; Deng X; Reckel S; Luty SB; Sun H; Gorenstein J; Hughes SB; Bottomly D; Wilmot B; McWeeney SK; Radich J; Hantschel O; Middleton RE; Gray NS; Druker BJ; Tyner JW
Cancer Res; 2016 Jan; 76(1):127-38. PubMed ID: 26677978
[TBL] [Abstract][Full Text] [Related]
11. HOXB7 and Hsa-miR-222 as the Potential Therapeutic Candidates for Metastatic Colorectal Cancer.
Iman M; Mostafavi SS; Arab SS; Azimzadeh S; Poorebrahim M
Recent Pat Anticancer Drug Discov; 2016; 11(4):434-443. PubMed ID: 27855613
[TBL] [Abstract][Full Text] [Related]
12. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
[TBL] [Abstract][Full Text] [Related]
13. KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies.
Wen Q; Dunne PD; O'Reilly PG; Li G; Bjourson AJ; McArt DG; Hamilton PW; Zhang SD
Oncotarget; 2017 Jan; 8(2):3206-3225. PubMed ID: 27965461
[TBL] [Abstract][Full Text] [Related]
14. Benzopyrimidodiazepinone inhibitors of TNK2.
Groendyke BJ; Powell CE; Feru F; Gero TW; Li Z; Szabo H; Pang K; Feutrill J; Chen B; Li B; Gray NS; Scott DA
Bioorg Med Chem Lett; 2020 Feb; 30(4):126948. PubMed ID: 31928839
[TBL] [Abstract][Full Text] [Related]
15. Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines.
Schlicker A; Beran G; Chresta CM; McWalter G; Pritchard A; Weston S; Runswick S; Davenport S; Heathcote K; Castro DA; Orphanides G; French T; Wessels LF
BMC Med Genomics; 2012 Dec; 5():66. PubMed ID: 23272949
[TBL] [Abstract][Full Text] [Related]
16. Antibody targeting of claudin-1 as a potential colorectal cancer therapy.
Cherradi S; Ayrolles-Torro A; Vezzo-Vié N; Gueguinou N; Denis V; Combes E; Boissière F; Busson M; Canterel-Thouennon L; Mollevi C; Pugnière M; Bibeau F; Ychou M; Martineau P; Gongora C; Del Rio M
J Exp Clin Cancer Res; 2017 Jun; 36(1):89. PubMed ID: 28659146
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
Sartore-Bianchi A; Ardini E; Bosotti R; Amatu A; Valtorta E; Somaschini A; Raddrizzani L; Palmeri L; Banfi P; Bonazzina E; Misale S; Marrapese G; Leone A; Alzani R; Luo D; Hornby Z; Lim J; Veronese S; Vanzulli A; Bardelli A; Martignoni M; Davite C; Galvani A; Isacchi A; Siena S
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26563355
[TBL] [Abstract][Full Text] [Related]
18. Identification of key genes in colorectal cancer using random walk with restart.
Cui X; Shen K; Xie Z; Liu T; Zhang H
Mol Med Rep; 2017 Feb; 15(2):867-872. PubMed ID: 28000901
[TBL] [Abstract][Full Text] [Related]
19. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.
Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S
Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic inhibition of SGK1 suppresses colorectal cancer.
Liang X; Lan C; Jiao G; Fu W; Long X; An Y; Wang K; Zhou J; Chen T; Li Y; Xu J; Huang Q; Xu B; Xiao J
Exp Mol Med; 2017 Nov; 49(11):e399. PubMed ID: 29170478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]